Medical Technologies

Reagent Kit for Determining KRAS Gene Mutation Status by Real-Time PCR in Human Genomic DNA Samples from FFPE Tissue (Test-KRAS-Tissue) per TU 21.20.23-006-97638376-2016

Reagent Kit for Determining KRAS Gene Mutation Status by Real-Time PCR in Human Genomic DNA Samples from FFPE Tissue (Test-KRAS-Tissue) per TU 21.20.23-006-97638376-2016

"Test-KRAS-Tissue" Reagent Kit

The "Test-KRAS-Tissue" kit is designed for detecting KRAS gene mutations using real-time PCR. The kit includes the following components:

PCR Mixes

  • Gly12Ser (G12S), 120 μL — 1 tube
  • Gly12Arg (G12R), 120 μL — 1 tube
  • Gly12Cys (G12C), 120 μL — 1 tube
  • Gly12Asp (G12D), 120 μL — 1 tube
  • Gly12Ala (G12A), 120 μL — 1 tube
  • Gly12Val (G12V), 120 μL — 1 tube
  • Gly13Asp (G13D), 120 μL — 1 tube

Control Samples

  • Positive control (PCO, K+), 420 μL — 1 tube
  • Negative control (OCO, K−), 420 μL — 1 tube

Enzyme

  • Taq DNA polymerase, 1000 μL — 2 tubes

Documentation

  • User manual — 1 copy
  • Quality certificate — 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Determining KRAS Gene Mutation Status by Real-Time PCR in Human Genomic DNA Samples from FFPE Tissue (Test-KRAS-Tissue) per TU 21.20.23-006-97638376-2016, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Copyright MAXXmarketing GmbH
JoomShopping Download & Support